These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 16720593

  • 1. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
    Atthobari J, Brantsma AH, Gansevoort RT, Visser ST, Asselbergs FW, van Gilst WH, de Jong PE, de Jong-van den Berg LT, PREVEND study group.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3106-14. PubMed ID: 16720593
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J, Asselbergs FW, Boersma C, de Vries R, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ, PREVEND IT Study Group.
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [Abstract] [Full Text] [Related]

  • 3. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
    Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH, Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators.
    Circulation; 2004 Nov 02; 110(18):2809-16. PubMed ID: 15492322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group.
    Nephrol Dial Transplant; 2008 Dec 02; 23(12):3851-8. PubMed ID: 18641082
    [Abstract] [Full Text] [Related]

  • 6. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FF, de Jong-van den Berg LT, de Jong PE, Postma MJ, Prevention of Renal and Vascular End Stage Disease Study Group.
    Clin Ther; 2010 Jun 02; 32(6):1103-21. PubMed ID: 20637965
    [Abstract] [Full Text] [Related]

  • 7. Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial.
    Geluk CA, Asselbergs FW, Hillege HL, Bakker SJ, de Jong PE, Zijlstra F, van Gilst WH.
    Eur Heart J; 2005 Jul 02; 26(13):1314-20. PubMed ID: 15820998
    [Abstract] [Full Text] [Related]

  • 8. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM, Penning-van Beest FJ, Johansson S, Stalenhoef AF, Herings RM.
    Curr Med Res Opin; 2009 Nov 02; 25(11):2621-9. PubMed ID: 19743959
    [Abstract] [Full Text] [Related]

  • 9. Differences between statins on clinical endpoints: a population-based cohort study.
    Dieleman JP, van Wyk JT, van Wijk MA, van Herpen G, Straus SM, Dunselman H, Sturkenboom MC.
    Curr Med Res Opin; 2005 Sep 02; 21(9):1461-8. PubMed ID: 16197665
    [Abstract] [Full Text] [Related]

  • 10. Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.
    Tonelli M, Isles C, Craven T, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, West M, Packard C, Curhan GC.
    Circulation; 2005 Jul 12; 112(2):171-8. PubMed ID: 15998677
    [Abstract] [Full Text] [Related]

  • 11. Impact of weight change on albuminuria in the general population.
    Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, Gansevoort RT.
    Nephrol Dial Transplant; 2007 Jun 12; 22(6):1619-27. PubMed ID: 17360767
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Paulsen L, Holm C, Bech JN, Starklint J, Pedersen EB.
    Nephrol Dial Transplant; 2008 May 12; 23(5):1556-61. PubMed ID: 18065809
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?
    Lingsma HF, Steyerberg EW, Scholte op Reimer WJ, van Domburg R, Dippel DW, Netherlands Stroke Survey Investigators.
    Acta Neurol Scand; 2010 Jul 12; 122(1):15-20. PubMed ID: 20047571
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discrepancy between results of randomized control studies and retrospective analysis: the case of statin therapy effect on one-year mortality in patients with decompensated heart failure.
    Nevzorov R, Novack V, Henkin Y, Kobal SL, Jotkowitz A, Porath A.
    Eur J Intern Med; 2009 Sep 12; 20(5):494-8. PubMed ID: 19712852
    [Abstract] [Full Text] [Related]

  • 18. Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery.
    Ouattara A, Benhaoua H, Le Manach Y, Mabrouk-Zerguini N, Itani O, Osman A, Landi M, Riou B, Coriat P.
    J Cardiothorac Vasc Anesth; 2009 Oct 12; 23(5):633-8. PubMed ID: 19362495
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. What predicts progression and regression of urinary albumin excretion in the nondiabetic population?
    Brantsma AH, Atthobari J, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT.
    J Am Soc Nephrol; 2007 Feb 12; 18(2):637-45. PubMed ID: 17215442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.